25,135 results
Environment
PROJECT NUMBER • 2005-029
PROJECT STATUS:
COMPLETED

Seafood CRC: Factors limiting resilience and recovery of fished abalone populations

The aims of this project were to: Determine the efficacy of translocation of mature abalone for stock rebuilding Identify key ecological processes that limit stock recovery Quantify the scale of 'spillover' from translocated populations Cost-benefit analysis of rehabilitated...
ORGANISATION:
University of Tasmania (UTAS)
People
PROJECT NUMBER • 2009-731
PROJECT STATUS:
COMPLETED

Seafood CRC: Develop priority R&D projects for the Australian Council of Prawn Fisheries

Since its inception the Seafood CRC had a budget of approximately $3m available for R&D projects on behalf of its member, the Australian Council of Prawn Fishers (ACPF). However, at the start of the CRC, the ACPF had a number of problems that ensured no sustained effort would be applied to...
ORGANISATION:
Shearwater Consulting Pty Ltd
Industry
PROJECT NUMBER • 2006-226
PROJECT STATUS:
COMPLETED

Seafood CRC: securing and enhancing the Sydney rock oyster breeding program

The Select Oyster Company breeding plan has been amended to include a comprehensive manual of protocols for pair mating Sydney rock oysters (4.1). The association between phenoloxidase (PO) and QX resistance has been confirmed and a sensitive test for PO genotypes has been developed so that the...
ORGANISATION:
Department of Primary Industries and Regional Development (NSW)
Adoption
PROJECT NUMBER • 2019-082
PROJECT STATUS:
CURRENT

Extension and synthesis of key FRDC research areas

Harvest strategies provide pre-planned actions ensuring sustainable fish populations while considering economic and social aspects. This report summarises an extension webinar where researchers, managers, and stakeholders discussed the development and implementation of these strategies. The...
ORGANISATION:
Fisheries Research and Development Corporation (FRDC)

SCRC: Review of health benefit research and development relevant to the Australian seafood industry and members of the Australian Seafood CRC

Project number: 2007-714
Project Status:
Completed
Budget expenditure: $0.00
Principal Investigator: Lynne Cobiac
Organisation: Flinders University
Project start/end date: 9 Sep 2007 - 1 Nov 2007
Contact:
FRDC

Need

Development of a position on functional foods to support the Seafood CRC workshop and potential rebid for funds for Program 3 (Health benefits of Seafood)

Final report

ISBN: 978-0-9752258-8-2
Author: Lily Chan
Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

Final Report • 2007-11-09 • 755.05 KB
2007-714-DLD.pdf

Summary

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

View Filter

Species

Organisation